![]() PepGen PepGen is a clinical-stage biotechnology company developing next-generation of oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases. | |||||
Founding Date | Founding Date 2006 | Founding Date 2014 | Founding Date 2000 | Founding Date 2016 | Founding Date 2018 |
Type | Type Private | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Maitland, US HQ | Locations HQ | Locations Treize-Septiers, FR HQ | Locations Cambridge, GB HQ | Locations Boston, US HQ |
Employees | Employees 425% decrease | Employees N/A | Employees 122 | Employees 3014% decrease | Employees 8127% increase |
Financial | |||||
Net income | Net income N/A | Net income (kr10.7m) (FY, 2024) | Net income N/A | Net income N/A | Net income ($89.7m) (FY, 2025) |

Audientes is a biotechnology company that develops treatments for muscle diseases.
View company
Clean Cells is a company that specializes in biosafety testings and cell therapy.
View company
Mogrify is a biotech company advancing cell therapies.
View company
PepGen is a clinical-stage biotechnology company developing next-generation of oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases.
View company